Ethylglucuronide (ETG) Rapid Test

Ethylglucuronide, commonly written as ETG, is a direct metabolite of ethanol. When alcohol enters the body, a small portion is converted into ETG and eliminated through urine. Because ETG can remain detectable after alcohol itself has left the blood or breath, the ETG urine test is used as a marker of recent alcohol exposure.

• The ETG rapid test detects ethylglucuronide in a urine specimen. A urine sample is applied to the test device, and the result is interpreted according to the product insert.
• The 50ng/ml cut-off means the test is designed for sensitive preliminary screening at the stated threshold.
• The Ethylglucuronide ETG Rapid Test 50ng/ml provides a qualitative result, which means it indicates whether ETG is detected at or above the test cut-off. It is not intended to measure the exact amount of alcohol consumed.

• Urine is one of the most practical specimen types for ETG screening because it is non-invasive, easy to collect, and suitable for rapid testing.
• Urine-based ETG testing is commonly used when alcohol exposure needs to be detected beyond the short window of breath or blood alcohol testing.
• The ETG urine rapid test is useful where a fast preliminary result is required before confirmatory testing.

The LARKSOIS Pharma Ethylglucuronide ETG Rapid Test 50ng/ml may be used in professional diagnostic and institutional screening environments.

Applications

• Alcohol abstinence monitoring programs
• Rehabilitation and recovery support centers
• Workplace alcohol screening programs
• Forensic and legal screening environments
• Clinical alcohol exposure assessment
• Pre-employment or compliance testing, where legally permitted
• Drug-of-abuse rapid test panels
• International laboratory and diagnostic distribution channels

Instructions

• Sensitive 50ng/ml cut-off
• Urine-based rapid test format
• Designed for alcohol exposure screening
• Easy-to-read qualitative result
• Suitable for professional testing environments
• Helpful for clinical, workplace, and rehabilitation programs
• Useful in drug-of-abuse screening portfolios
• Supplied under LARKSOIS Pharma’s international diagnostic product focus

• The detection window of an ETG urine test depends on several factors, including alcohol amount, time since exposure, hydration status, metabolism, kidney function, and test sensitivity.
• A positive ETG rapid test result generally indicates recent ethanol exposure, but results should be interpreted carefully.
• Positive screening results should be reviewed with testing policy, specimen quality, clinical history, and confirmatory testing requirements.

The Ethylglucuronide (ETG) Rapid Test uses a rapid urine screening method for qualitative detection of ETG. It is designed to provide a preliminary screening result at the stated 50ng/ml cut-off.

Benefits

• Urine-based rapid screening format
• 50ng/ml ETG cut-off
• Designed for alcohol exposure screening
• Suitable for professional diagnostic use
• Supports fast preliminary results
• Useful for rehabilitation, workplace, forensic, and clinical monitoring workflows
• Applicable for laboratories, clinics, and institutions
• Supports international alcohol exposure screening requirements

The Ethylglucuronide (ETG) Rapid Test is designed for urine specimens. Urine is commonly used for ETG screening because it is practical, non-invasive, and suitable for professional alcohol exposure monitoring workflows.

Guidance

• Use urine specimens only
• Use clean sample collection procedures
• Follow the product insert carefully
• Treat all urine samples as potentially biohazardous
• Interpret results within the stated reading window
• Use confirmatory testing where required by clinical, legal, workplace, forensic, or institutional policy

Note

A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Ethylglucuronide (ETG) Rapid Test by LARKSOIS Pharma has a stated cut-off of 50ng/ml. This means the test is designed to screen for ETG in urine at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

• The ETG rapid urine test plays an important role in alcohol exposure screening because ETG may remain detectable after ethanol itself is no longer measurable in breath or blood.
• In professional testing programs, rapid screening helps identify samples that may require further laboratory evaluation.
• For global buyers, the Ethylglucuronide ETG Rapid Test 50ng/ml is an important product for diagnostic portfolios, rehabilitation support, workplace screening, forensic testing, and abstinence monitoring programs.

Steps

• Bring the test device and urine specimen to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect urine using a clean sample collection procedure
• Apply the urine specimen according to the product insert
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Ethylglucuronide (ETG) Rapid Test.

Positive

A positive result suggests that ethylglucuronide may be present in the urine specimen at or above the stated cut-off. Positive results are preliminary unless confirmed by an appropriate laboratory method.

Negative

A negative result suggests that ethylglucuronide was not detected or was below the test cut-off at the time of testing. A negative result does not replace clinical or professional judgment.

Invalid

If the control indicator does not appear, the result is invalid. The test should be repeated with a new device and fresh urine specimen according to the product insert.

Instructions

• Store in a cool and dry place
• Keep away from direct sunlight
• Do not freeze the test kit
• Keep the pouch sealed until use
• Avoid moisture and heat exposure
• Do not use after expiry date
• Keep away from children and unauthorized handling

Instructions

• For professional screening use only
• Use urine specimen only
• Do not use expired, damaged, or opened test kits
• Read the instruction leaflet before testing
• Follow local laboratory and regulatory guidelines
• Do not interpret results outside the recommended reading time
• Positive results may require confirmatory laboratory testing
• Results should not be used as the only basis for medical, legal, employment, or disciplinary decisions

LARKSOIS Pharma supplies pharmaceutical and diagnostic products for international healthcare markets. The Ethylglucuronide ETG Rapid Test 50ng/ml is designed for distributors, laboratories, clinics, rehabilitation centers, and institutional buyers who need reliable urine-based alcohol exposure screening products.

Advantages

• Sensitive 50ng/ml ETG cut-off
• Urine specimen compatibility
• Rapid qualitative screening format
• Suitable for professional diagnostic programs
• Useful for rehabilitation, workplace, forensic, and institutional testing
• Supports preliminary alcohol exposure screening workflows
• International product positioning under LARKSOIS Pharma